The global Human Microbiome Sequencing market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Baseclear B.V.
Novogene Corporation
Clinical Microbiomics A/S
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Illumina, Inc.
Charles River Laboratories International Inc.
Oxford Nanopore Technologies, Inc.
GENEWIZ, Inc.
Eurofins Scientific SE
OraSure Technologies, Inc.
Viome, Inc.
Microba
Pacific Biosciences of California, Inc.
Molzym GmbH & Co. KG
CosmosID
Thermo Fisher Scientific Inc.
QIAGEN N.V.
Microbiome Insights Inc.
Leucine Rich Bio Pvt. Ltd.
Second Genome, Inc.
By Types:
Next-Generation Sequencing
Traditional Sequencing Technologies
Other
By Applications:
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Human Microbiome Sequencing Market Size Analysis from 2023 to 2028
1.5.1 Global Human Microbiome Sequencing Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Human Microbiome Sequencing Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Human Microbiome Sequencing Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Human Microbiome Sequencing Industry Impact
Chapter 2 Global Human Microbiome Sequencing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Human Microbiome Sequencing (Volume and Value) by Type
2.1.1 Global Human Microbiome Sequencing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Human Microbiome Sequencing Revenue and Market Share by Type (2017-2022)
2.2 Global Human Microbiome Sequencing (Volume and Value) by Application
2.2.1 Global Human Microbiome Sequencing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Human Microbiome Sequencing Revenue and Market Share by Application (2017-2022)
2.3 Global Human Microbiome Sequencing (Volume and Value) by Regions
2.3.1 Global Human Microbiome Sequencing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Human Microbiome Sequencing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Human Microbiome Sequencing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Human Microbiome Sequencing Consumption by Regions (2017-2022)
4.2 North America Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Human Microbiome Sequencing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Human Microbiome Sequencing Market Analysis
5.1 North America Human Microbiome Sequencing Consumption and Value Analysis
5.1.1 North America Human Microbiome Sequencing Market Under COVID-19
5.2 North America Human Microbiome Sequencing Consumption Volume by Types
5.3 North America Human Microbiome Sequencing Consumption Structure by Application
5.4 North America Human Microbiome Sequencing Consumption by Top Countries
5.4.1 United States Human Microbiome Sequencing Consumption Volume from 2017 to 2022
5.4.2 Canada Human Microbiome Sequencing Consumption Volume from 2017 to 2022
5.4.3 Mexico Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Human Microbiome Sequencing Market Analysis
6.1 East Asia Human Microbiome Sequencing Consumption and Value Analysis
6.1.1 East Asia Human Microbiome Sequencing Market Under COVID-19
6.2 East Asia Human Microbiome Sequencing Consumption Volume by Types
6.3 East Asia Human Microbiome Sequencing Consumption Structure by Application
6.4 East Asia Human Microbiome Sequencing Consumption by Top Countries
6.4.1 China Human Microbiome Sequencing Consumption Volume from 2017 to 2022
6.4.2 Japan Human Microbiome Sequencing Consumption Volume from 2017 to 2022
6.4.3 South Korea Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 7 Europe Human Microbiome Sequencing Market Analysis
7.1 Europe Human Microbiome Sequencing Consumption and Value Analysis
7.1.1 Europe Human Microbiome Sequencing Market Under COVID-19
7.2 Europe Human Microbiome Sequencing Consumption Volume by Types
7.3 Europe Human Microbiome Sequencing Consumption Structure by Application
7.4 Europe Human Microbiome Sequencing Consumption by Top Countries
7.4.1 Germany Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.2 UK Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.3 France Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.4 Italy Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.5 Russia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.6 Spain Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Human Microbiome Sequencing Consumption Volume from 2017 to 2022
7.4.9 Poland Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Human Microbiome Sequencing Market Analysis
8.1 South Asia Human Microbiome Sequencing Consumption and Value Analysis
8.1.1 South Asia Human Microbiome Sequencing Market Under COVID-19
8.2 South Asia Human Microbiome Sequencing Consumption Volume by Types
8.3 South Asia Human Microbiome Sequencing Consumption Structure by Application
8.4 South Asia Human Microbiome Sequencing Consumption by Top Countries
8.4.1 India Human Microbiome Sequencing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Human Microbiome Sequencing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Human Microbiome Sequencing Market Analysis
9.1 Southeast Asia Human Microbiome Sequencing Consumption and Value Analysis
9.1.1 Southeast Asia Human Microbiome Sequencing Market Under COVID-19
9.2 Southeast Asia Human Microbiome Sequencing Consumption Volume by Types
9.3 Southeast Asia Human Microbiome Sequencing Consumption Structure by Application
9.4 Southeast Asia Human Microbiome Sequencing Consumption by Top Countries
9.4.1 Indonesia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.2 Thailand Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.3 Singapore Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.5 Philippines Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Human Microbiome Sequencing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Human Microbiome Sequencing Market Analysis
10.1 Middle East Human Microbiome Sequencing Consumption and Value Analysis
10.1.1 Middle East Human Microbiome Sequencing Market Under COVID-19
10.2 Middle East Human Microbiome Sequencing Consumption Volume by Types
10.3 Middle East Human Microbiome Sequencing Consumption Structure by Application
10.4 Middle East Human Microbiome Sequencing Consumption by Top Countries
10.4.1 Turkey Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.3 Iran Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.5 Israel Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.6 Iraq Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.7 Qatar Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Human Microbiome Sequencing Consumption Volume from 2017 to 2022
10.4.9 Oman Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 11 Africa Human Microbiome Sequencing Market Analysis
11.1 Africa Human Microbiome Sequencing Consumption and Value Analysis
11.1.1 Africa Human Microbiome Sequencing Market Under COVID-19
11.2 Africa Human Microbiome Sequencing Consumption Volume by Types
11.3 Africa Human Microbiome Sequencing Consumption Structure by Application
11.4 Africa Human Microbiome Sequencing Consumption by Top Countries
11.4.1 Nigeria Human Microbiome Sequencing Consumption Volume from 2017 to 2022
11.4.2 South Africa Human Microbiome Sequencing Consumption Volume from 2017 to 2022
11.4.3 Egypt Human Microbiome Sequencing Consumption Volume from 2017 to 2022
11.4.4 Algeria Human Microbiome Sequencing Consumption Volume from 2017 to 2022
11.4.5 Morocco Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Human Microbiome Sequencing Market Analysis
12.1 Oceania Human Microbiome Sequencing Consumption and Value Analysis
12.2 Oceania Human Microbiome Sequencing Consumption Volume by Types
12.3 Oceania Human Microbiome Sequencing Consumption Structure by Application
12.4 Oceania Human Microbiome Sequencing Consumption by Top Countries
12.4.1 Australia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 13 South America Human Microbiome Sequencing Market Analysis
13.1 South America Human Microbiome Sequencing Consumption and Value Analysis
13.1.1 South America Human Microbiome Sequencing Market Under COVID-19
13.2 South America Human Microbiome Sequencing Consumption Volume by Types
13.3 South America Human Microbiome Sequencing Consumption Structure by Application
13.4 South America Human Microbiome Sequencing Consumption Volume by Major Countries
13.4.1 Brazil Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.2 Argentina Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.3 Columbia Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.4 Chile Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.6 Peru Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Human Microbiome Sequencing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Human Microbiome Sequencing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Human Microbiome Sequencing Business
14.1 Baseclear B.V.
14.1.1 Baseclear B.V. Company Profile
14.1.2 Baseclear B.V. Human Microbiome Sequencing Product Specification
14.1.3 Baseclear B.V. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Novogene Corporation
14.2.1 Novogene Corporation Company Profile
14.2.2 Novogene Corporation Human Microbiome Sequencing Product Specification
14.2.3 Novogene Corporation Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Clinical Microbiomics A/S
14.3.1 Clinical Microbiomics A/S Company Profile
14.3.2 Clinical Microbiomics A/S Human Microbiome Sequencing Product Specification
14.3.3 Clinical Microbiomics A/S Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd
14.4.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Profile
14.4.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product Specification
14.4.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Illumina, Inc.
14.5.1 Illumina, Inc. Company Profile
14.5.2 Illumina, Inc. Human Microbiome Sequencing Product Specification
14.5.3 Illumina, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Charles River Laboratories International Inc.
14.6.1 Charles River Laboratories International Inc. Company Profile
14.6.2 Charles River Laboratories International Inc. Human Microbiome Sequencing Product Specification
14.6.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Oxford Nanopore Technologies, Inc.
14.7.1 Oxford Nanopore Technologies, Inc. Company Profile
14.7.2 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product Specification
14.7.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 GENEWIZ, Inc.
14.8.1 GENEWIZ, Inc. Company Profile
14.8.2 GENEWIZ, Inc. Human Microbiome Sequencing Product Specification
14.8.3 GENEWIZ, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Eurofins Scientific SE
14.9.1 Eurofins Scientific SE Company Profile
14.9.2 Eurofins Scientific SE Human Microbiome Sequencing Product Specification
14.9.3 Eurofins Scientific SE Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 OraSure Technologies, Inc.
14.10.1 OraSure Technologies, Inc. Company Profile
14.10.2 OraSure Technologies, Inc. Human Microbiome Sequencing Product Specification
14.10.3 OraSure Technologies, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Viome, Inc.
14.11.1 Viome, Inc. Company Profile
14.11.2 Viome, Inc. Human Microbiome Sequencing Product Specification
14.11.3 Viome, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Microba
14.12.1 Microba Company Profile
14.12.2 Microba Human Microbiome Sequencing Product Specification
14.12.3 Microba Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Pacific Biosciences of California, Inc.
14.13.1 Pacific Biosciences of California, Inc. Company Profile
14.13.2 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product Specification
14.13.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Molzym GmbH & Co. KG
14.14.1 Molzym GmbH & Co. KG Company Profile
14.14.2 Molzym GmbH & Co. KG Human Microbiome Sequencing Product Specification
14.14.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 CosmosID
14.15.1 CosmosID Company Profile
14.15.2 CosmosID Human Microbiome Sequencing Product Specification
14.15.3 CosmosID Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Thermo Fisher Scientific Inc.
14.16.1 Thermo Fisher Scientific Inc. Company Profile
14.16.2 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product Specification
14.16.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 QIAGEN N.V.
14.17.1 QIAGEN N.V. Company Profile
14.17.2 QIAGEN N.V. Human Microbiome Sequencing Product Specification
14.17.3 QIAGEN N.V. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Microbiome Insights Inc.
14.18.1 Microbiome Insights Inc. Company Profile
14.18.2 Microbiome Insights Inc. Human Microbiome Sequencing Product Specification
14.18.3 Microbiome Insights Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Leucine Rich Bio Pvt. Ltd.
14.19.1 Leucine Rich Bio Pvt. Ltd. Company Profile
14.19.2 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product Specification
14.19.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Second Genome, Inc.
14.20.1 Second Genome, Inc. Company Profile
14.20.2 Second Genome, Inc. Human Microbiome Sequencing Product Specification
14.20.3 Second Genome, Inc. Human Microbiome Sequencing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Human Microbiome Sequencing Market Forecast (2023-2028)
15.1 Global Human Microbiome Sequencing Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Human Microbiome Sequencing Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Human Microbiome Sequencing Value and Growth Rate Forecast (2023-2028)
15.2 Global Human Microbiome Sequencing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Human Microbiome Sequencing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Human Microbiome Sequencing Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Human Microbiome Sequencing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Human Microbiome Sequencing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Human Microbiome Sequencing Consumption Forecast by Type (2023-2028)
15.3.2 Global Human Microbiome Sequencing Revenue Forecast by Type (2023-2028)
15.3.3 Global Human Microbiome Sequencing Price Forecast by Type (2023-2028)
15.4 Global Human Microbiome Sequencing Consumption Volume Forecast by Application (2023-2028)
15.5 Human Microbiome Sequencing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Oct 2024 |
| Category : Services |
Pages : 129 |
| Price : US$ 3500 |
Date : Oct 2024 |
| Category : Services |
Pages : 120 |
Request Sample 
Request Discount 
Inquire Before Buy
